Literature DB >> 3811242

Nucleotide sequence of the adenovirus type 40 inverted terminal repeat: close relation to that of adenovirus type 5.

M Ishino, Y Sawada, T Yaegashi, M Demura, K Fujinaga.   

Abstract

Human adenovirus type 40 (Ad40) is a pathogen that causes acute infantile gastroenteritis. Ad40 has the distinct characteristic of being difficult to propagate in conventional cultured human cells. The nucleotide sequence of the inverted terminal repeat (ITR) of Ad40, which includes the origin of adenoviral DNA replication, was determined using recombinant plasmid DNA. By using our newly developed program to express the ITR homologies simply, we found that the ITR of Ad40, which is 163 nucleotides long, was related most closely to that of adenovirus type 5, which replicates efficiently.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3811242     DOI: 10.1016/0042-6822(87)90421-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  4 in total

1.  Identification of two distinct regions within the adenovirus minimal origin of replication that are required for adenovirus type 4 DNA replication in vitro.

Authors:  S M Temperley; C R Burrow; T J Kelly; R T Hay
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

2.  Unusual splice sites in the E1A-E1B cotranscripts synthesized in adenovirus type 40-infected A549 cells.

Authors:  S Ishida; Y Fujinaga; K Fujinaga; N Sakamoto; S Hashimoto
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

3.  Fastidious human adenovirus type 40 can propagate efficiently and produce plaques on a human cell line, A549, derived from lung carcinoma.

Authors:  S Hashimoto; N Sakakibara; H Kumai; M Nakai; S Sakuma; S Chiba; K Fujinaga
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

Review 4.  Methods and Applications of CRISPR-Mediated Base Editing in Eukaryotic Genomes.

Authors:  Gaelen T Hess; Josh Tycko; David Yao; Michael C Bassik
Journal:  Mol Cell       Date:  2017-10-05       Impact factor: 17.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.